RELAPSED HODGKIN'S DISEASE, ADULT
Clinical trials for RELAPSED HODGKIN'S DISEASE, ADULT explained in plain language.
Never miss a new study
Get alerted when new RELAPSED HODGKIN'S DISEASE, ADULT trials appear
Sign up with your email to follow new studies for RELAPSED HODGKIN'S DISEASE, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug reboot the immune system after a stem cell transplant?
Disease control OngoingThis phase 2 trial tests whether adding isatuximab to standard stem cell transplant procedures can help the immune system better fight multiple myeloma and certain lymphomas. Participants are randomly assigned to receive either standard transplant care alone or isatuximab plus st…
Matched conditions: RELAPSED HODGKIN'S DISEASE, ADULT
Phase: PHASE2 • Sponsor: Divaya Bhutani • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New hope for tough hodgkin lymphoma: immune drugs tested alone or together
Disease control OngoingThis study tests two immune-boosting drugs, ipilimumab and nivolumab, in people with classic Hodgkin lymphoma that has returned or not responded to prior therapy. The goal is to see if giving these drugs alone or together can shrink tumors. The trial involves 13 adults with measu…
Matched conditions: RELAPSED HODGKIN'S DISEASE, ADULT
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC